Leo Pharma Enters Partnership to Develop Topical Treatment for Rare Skin Cancer
The Danish company Leo Pharma and the US biotech PellePharm have joined forces to develop…
November 21, 2018 - 2 minutes
Leo Pharma
Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis
Though the psoriasis market is teeming with effective products, companies have developed ways to devise…
October 17, 2017 - 7 minutes
Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links
Update (20/07/2017): The European Commision has granted LEO Pharma marketing authorization for Kyntheum (brodalumab), making it…
July 20, 2017 - 3 minutes
Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma
argenx's 2015 deal with Leo Pharma for anti-inflammatory antibodies continues to pay off, though it hasn't…
June 20, 2017 - 1 minute
Antibody Therapies are here to Revolutionize Dermatology
Leo Pharma is offering MorphoSys no less than €111.5M per antibody treatment with applications in…
November 2, 2016 - 2 minutes
New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira
New results from a Phase III trial show that guselkumab, an antibody therapy for the autoimmune…
October 5, 2016 - 3 minutes
Danish Pharma enters in the Biologics arena with Antibody Buy-out
Leo Pharma is acquiring rights to two of AstraZeneca's candidates. The targeted indications are atopic…
July 4, 2016 - 3 minutes
When the Llama met the Lion: Antibodies Unlock Milestone Payment for Skin Disease
ArGEN-X in Ghent (Belgium) combines the diversity of the llama immune system with a clinical antibody…
February 3, 2016 - 2 minutes
Infographic: The Anatomy of European Biotech
Which part of our body do European biotechs prefer to target? And how diversified are…
December 10, 2015 - 1 minute
